These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 27393848

  • 1. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, Ude M.
    Int J Cardiol; 2016 Oct 01; 220():668-76. PubMed ID: 27393848
    [Abstract] [Full Text] [Related]

  • 2. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K, Anderson LN, Butt DA, Quan H, Hemmelgarn BR, Campbell NR, McAlister FA, Hypertension Outcome and Surveillance Team.
    Can J Cardiol; 2014 Jun 06; 30(6):647-52. PubMed ID: 24882536
    [Abstract] [Full Text] [Related]

  • 4. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM.
    Circulation; 2011 Apr 19; 123(15):1611-21. PubMed ID: 21464050
    [Abstract] [Full Text] [Related]

  • 5. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM, Lee JY, Choi YJ, Kim B, Choi KH, Kong J, Oh JM, Shin WG, Lee HY.
    J Korean Med Sci; 2015 Dec 19; 30(12):1800-6. PubMed ID: 26713055
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
    Baggarly SA, Kemp RJ, Wang X, Magoun AD.
    Res Social Adm Pharm; 2014 Dec 19; 10(6):e99-e112. PubMed ID: 24731547
    [Abstract] [Full Text] [Related]

  • 7. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.
    Orv Hetil; 2019 Mar 19; 160(9):343-348. PubMed ID: 30798621
    [Abstract] [Full Text] [Related]

  • 8. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs.
    Wang TD, Chen YH, Huang CH, Chen WJ, Chen MF.
    Hypertension; 2014 May 19; 63(5):958-67. PubMed ID: 24446059
    [Abstract] [Full Text] [Related]

  • 9. Understanding Adherence and Prescription Patterns Using Large-Scale Claims Data.
    Bjarnadóttir MV, Malik S, Onukwugha E, Gooden T, Plaisant C.
    Pharmacoeconomics; 2016 Feb 19; 34(2):169-79. PubMed ID: 26660349
    [Abstract] [Full Text] [Related]

  • 10. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 19; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 11. [Sex-specific antihypertensive drug therapy].
    Pühringer P, Gouya G, Reichardt B, Wolzt M.
    Wien Med Wochenschr; 2006 Sep 19; 156(17-18):498-500. PubMed ID: 17041806
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive persistence and drug class.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB.
    Can J Cardiol; 2002 Jun 19; 18(6):649-56. PubMed ID: 12107422
    [Abstract] [Full Text] [Related]

  • 13. [Medication adherence with the fixed combination of ramipril and amlodipine].
    Simonyi G, Ferenci T.
    Orv Hetil; 2014 Nov 23; 155(47):1882-8. PubMed ID: 25403283
    [Abstract] [Full Text] [Related]

  • 14. Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).
    Qvarnström M, Kahan T, Kieler H, Brandt L, Hasselström J, Boström KB, Manhem K, Hjerpe P, Wettermark B.
    Medicine (Baltimore); 2016 Oct 23; 95(40):e4908. PubMed ID: 27749548
    [Abstract] [Full Text] [Related]

  • 15. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP.
    J Hum Hypertens; 2005 Aug 23; 19(8):607-13. PubMed ID: 15920457
    [Abstract] [Full Text] [Related]

  • 16. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Jan 03; 157(1):30-4. PubMed ID: 26708684
    [Abstract] [Full Text] [Related]

  • 17. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
    Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV.
    Hypertension; 2011 Dec 03; 58(6):1008-13. PubMed ID: 22042809
    [Abstract] [Full Text] [Related]

  • 18. Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.
    Choi KH, Yu YM, Ah YM, Chang MJ, Lee JY.
    BMC Cardiovasc Disord; 2017 Aug 24; 17(1):232. PubMed ID: 28836946
    [Abstract] [Full Text] [Related]

  • 19. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J.
    Ann Pharmacother; 2005 Sep 24; 39(9):1401-8. PubMed ID: 16076920
    [Abstract] [Full Text] [Related]

  • 20. Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study.
    Hasford J, Schröder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G.
    Eur J Clin Pharmacol; 2007 Nov 24; 63(11):1055-61. PubMed ID: 17701032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.